MBM-17S
MBM-17S is a potent NIMA-related kinase 2 (Nek2) inhibitor, with an IC50 of 3 nM. MBM-17S effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-17S shows antitumor activities, and no obvious toxicity to mice.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2083621-91-2
- Formel: C36H40N6O10
- Molecular Weight:716.74
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
|
NEK2 3 nM (IC50) |
MBM-17S inhibits MGC-803, HCT-116, and Bel-7402 cells proliferation with IC50s of 0.48, 1.06, and 4.53 μM, respectively[1].
MBM-17S (0.25-1.0 μM; 24 hours) induced G2/M phase arrest and accumulation of cells with >4N content[1].
MBM-17S (0.5-1.0 μM; 24 hours) triggers apoptosis of cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT-116 and MGC-803 cells
-
Concentration:0.25-1.0 μM
-
Incubation Time:24 hours
-
Result:Obvious accumulation of cells in the G2/M phase with >4 N DNA content.
-
Cell Line:HCT-116 and MGC-803 cells
-
Concentration:0.5 μM, 1.0 μM
-
Incubation Time:24 hours
-
Result:For HCT-116 cells, the percentage of total apoptotic cells was 39.3%±3.8% and 47.1%±0.6% at 0.5 μM and 1.0 μM, respectively. For MGC-803 cells, the percentage of total apoptotic cells increased to 32.9%±4.6% and 41.1%±0.2% at 0.25 μM and 0.5 μM, respectively.
MBM-17S (1.0 mg/kg; i.v.) treatment shows CL, Vss, T1/2, AUC0-t, and AUC0-∞ values of 42.4 mL/min/kg, 4.06 L/kg, 2.42 hours, 386 ng/h/mL, and 405 ng/h/mL, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female BALB/c nu/nu mice (5-6 weeks, bearing HCT-116 xenografts)[1]
-
Dosage:20 mg/kg
-
Administration:Intraperitoneal injection; twice a day for 21 days
-
Result:Tmor growth was significantly suppressed.
-
Animal Model:Male Sprague Dawley (SD) rats[1]
-
Dosage:1.0 mg/kg
-
Administration:IV injection (Pharmacokinetic Analysis)
-
Result:The CL, Vss, T1/2, AUC0-t, and AUC0-∞ values of 42.4 mL/min/kg, 4.06 L/kg, 2.42 hours, 386 ng/h/mL, and 405 ng/h/mL, respectively.
Chemical Information
-
CAS. Nr. 2083621-91-2
-
Molecular Weight 716.74
-
Formel C36H40N6O10
-
SMILES
O=C(O)CCC(O)=O.O=C(O)CCC(O)=O.NC(C(C=C1)=C(OCC2=CC=CC=C2)C=C1C3=CN=C4N3C=CC(C5=CN(CCN(C)C)N=C5)=C4)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
MBM-17S Related Classifications
HY-101030A Related Classifications
Powered by Bioz